AI-generated · cited to primary sources · not investment advice · How we research
Navin Fluo.Intl.
Our verdict on Navin Fluo.Intl. isn’t the consensus take — see where we landed, and the one risk the bull case glosses over.
See the verdict — free →Does management do what it says?
The AHF capex project has been successfully commissioned and commercial supplies have commenced as of Q4 FY26. (3 met, 2 revised across 5 tracked commitments)
“And utilization for Nectar is again, as we had always said, this year, we would hit roughly 50% of the par. So, we are on track for that.”
The project remains on track for its Q3 FY27 commissioning timeline with a peak revenue potential of Rs. 600-825 Crs. (1 not yet due across 1 tracked commitment)
“The Chemours project to manufacture Opteon, a two-phase immersion cooling fluid is progressing well and is on track for completion by Q1 of FY '27.”
The project for Chemours remains on track for completion in the first quarter of the next fiscal year. (1 not yet due across 1 tracked commitment)
“Initial commercial capacity for manufacturing to enable adoption of innovative liquid cooling product... Targeted commissioning by Q1FY27”
The company expects to reach 75% to 80% capacity utilization for the Nectar project by the end of FY28. — target: 75% to 80% (+3 more commitments)
“But I think we are realistically talking about 75% to 80% is where we will get to by end of FY28.”
Strategic foray into High Growth Advanced Materials through partnership.
“Strategic Partnership with Chemours and foray into High Growth Advanced Materials”
See the full cited Management analysis of Navin Fluo.Intl.
How durable is the business?
The HPP segment showed significant expansion, with revenue growing 45% year-over-year, driven by higher sales volumes and better pricing (realizations). The segment's share of total revenue increased to 56% (Rs. 407 Cr out of Rs. 725.4 Cr). (5 expanding across 1 engine)
“Business Vertical - Specialty Chemicals... Revenues Rs. Crs... Q4 FY26 360... +39%”
The balance sheet has been further strengthened by a successful QIP of INR 750 crores, providing capital for an expanded capex frame. (1 expanding, 2 stable)
“As of 31 March 2026, our net debt to equity stood at 0.01x negligible, while both ROE and ROCE improved at 20% and 21%, respectively.”
The company has significantly increased its annual capex guidance from INR 500-600 crores to INR 700-1,000 crores to accelerate growth in advanced materials and electronic chemicals. (1 expanding, 1 stable)
“With the fund raise, I think it's fair to assume that our capex frame... will be expanded to INR700 crores to INR1,000 crores.”
Operating EBITDA margins expanded significantly by 992 basis points for the full year, reaching 32.6% due to better product mix and operational efficiencies. (1 expanding, 1 stable)
“Operating EBITDA Margin 32.6% + 992 bps Y-o-Y”
The moat is reinforced by the 'right to win' derived from Kigali Amendment quotas and long-term contracts in Specialty Chemicals and CDMO. (1 stable)
“See, again, we have a service play and in the service play, we work with global innovators. So frankly, their regulatory risks of the intermediates we supply to them are managed by them. We are working on some new innovation -- innovator molecules, which are part of the strategic pipeline of these global innovators.”
See the full cited Business Model analysis of Navin Fluo.Intl.
Where does growth come from?
The company has a strong pipeline of new products, having developed 13 new molecules in the past year, which provides high confidence for future factory usage.
“If you look at FY26, we have done in all, I believe, close to about 13 new molecules during the year. And that... gives us enough confidence to say that as we look into FY27, we have visibility almost up to about 80% of our capacity utilization.”
The company is nearing completion of a major Rs. 450 crore AHF (Anhydrous Hydrofluoric Acid) capex at Dahej, expected to commission by the end of Q2 FY26, which will provide critical raw material security. (1 steady across 1 signal)
“Backward Integration of key products to basic feedstock... offering a China-free alternative with minimal import dependency”
A new INR 75 crore debottlenecking project was approved this quarter to support a firm order for a novel Agrochemical Intermediate (AI), adding INR 140-160 crores in annual revenue. (2 new trend, 1 steady, 1 accelerating across 4 signals)
“European CDMO MSA : Successful completion of validation, commercial supplies started from cGMP4”
The Specialty Chemicals division is maintaining steady growth, supported by the ramp-up of the Dahej project launched in Dec '24 and the introduction of 3 new molecules in Q2 FY26. (1 steady, 1 accelerating across 2 signals)
“Operating EBITDA Margin 34.2% + 875 bps Y-o-Y”
The company is expanding its reach into new international markets and acquiring new customers as it grows.
“If you look at the export data, you will see that we've reached new geographies, new customers. A lot of it will change as you grow the business in the pace at which we are growing, yes.”
See the full cited Future Growth analysis of Navin Fluo.Intl.
What could break the thesis?
INTENSIFYING: Management noted that intense Chinese competition and pricing pressures continue to persist in the Agchem sector, potentially eroding volume recoveries. (1 intensifying)
“I think the Chinese intense competition, which we've talked about before, continues to remain, pressure on pricing remains...”
The risk remains stable but visibility has improved. The company achieved a milestone with a European partner and secured revenue visibility for the next three years, though it remains heavily reliant on EU majors. (1 stable)
“During the quarter, we achieved a significant milestone with our European CDMO partner... This engagement provides strong revenue visibility over the next three years.”
EASING: The company successfully raised INR 750 crores through a Qualified Institutional Placement (QIP) in July 2025, which management stated will be used to strengthen the balance sheet and fund capex. (1 easing, 2 stable)
“We raised INR750 crores... The proceeds from this fundraising will be deployed towards strengthening our balance sheet.”
The risk is EASING as Operating EBITDA margins improved significantly to 28.5% in Q1FY26 from 19.16% in Q1FY25, despite raw material costs rising in absolute terms. (5 easing)
“Operating EBITDA Margin 28.51% [vs] 19.16%... Raw Material 307.71 [vs] 230.39”
The risk is easing as the company leverages global trade deals (EU FTA, US trade deals) and expands its 'service provider' model for global majors, driving 60% YoY growth in Specialty Chemicals. (1 easing)
“we had started working proactively with the global majors to be their technology partners in their supply chain and not just a pure relationship which is transactional”
See the full cited Risk analysis of Navin Fluo.Intl.
Read the full thesis on Navin Fluo.Intl.
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.